Carrasco-Zafra Maria Isabel, Gómez-García Rafael, Ocaña-Riola Ricardo, Martín-Roselló Maria Luisa, Blanco-Reina Encarnación
Fundación Cudeca, 29631 Málaga, Spain.
Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.
J Clin Med. 2020 Jun 23;9(6):1960. doi: 10.3390/jcm9061960.
The current treatment approach for patients in palliative care (PC) requires a health model based on shared and individualised care, according to the degree of complexity encountered. The aims of this study were to describe the levels of complexity that may be present, to determine their most prevalent elements and to identify factors that may be related to palliative complexity in advanced-stage cancer patients. An observational retrospective study was performed of patients attended to at the Cudeca Hospice. Socio-demographic and clinical data were compiled, together with information on the patients' functional and performance status (according to the Palliative Performance Scale (PPS)). The level of complexity was determined by the Diagnostic Instrument of Complexity in Palliative Care (IDC-Pal©) and classified as highly complex, complex or non-complex. The impact of the independent variables on PC complexity was assessed by multinomial logistic regression analysis. Of the 501 patients studied, 44.8% presented a situation classed as highly complex and another 44% were considered complex. The highly complex items most frequently observed were the absence or insufficiency of family support and/or caregivers (24.3%) and the presence of difficult-to-control symptoms (17.3%). The complex item most frequently observed was an abrupt change in the level of functional autonomy (47.6%). The main factor related to the presence of high vs. non-complexity was that of performance status (odds ratio (OR) = 10.68, 95% confidence interval (CI) = 2.81-40.52, for PPS values < 40%). However, age was inversely related to high complexity. This study confirms the high level of complexity present in patients referred to a PC centre. Determining the factors related to this complexity could help physicians identify situations calling for timely referral for specialised PC, such as a low PPS score.
目前,姑息治疗(PC)患者的治疗方法需要一种基于共享和个性化护理的健康模式,并根据所遇到的复杂程度来确定。本研究的目的是描述可能存在的复杂程度水平,确定其最普遍的因素,并识别与晚期癌症患者姑息治疗复杂性相关的因素。对Cudeca临终关怀医院收治的患者进行了一项观察性回顾研究。收集了社会人口学和临床数据,以及有关患者功能和表现状态的信息(根据姑息治疗表现量表(PPS))。通过姑息治疗复杂性诊断工具(IDC-Pal©)确定复杂程度,并将其分类为高度复杂、复杂或非复杂。通过多项逻辑回归分析评估自变量对PC复杂性的影响。在研究的501名患者中,44.8%的情况被归类为高度复杂,另有44%被认为是复杂的。最常观察到的高度复杂项目是家庭支持和/或照顾者的缺乏或不足(24.3%)以及存在难以控制的症状(17.3%)。最常观察到的复杂项目是功能自主性水平的突然变化(47.6%)。与高复杂性与非复杂性存在相关的主要因素是表现状态(优势比(OR)=10.68,95%置信区间(CI)=2.81-40.52,PPS值<40%)。然而,年龄与高复杂性呈负相关。本研究证实了转诊至PC中心的患者存在高度复杂性。确定与此复杂性相关的因素有助于医生识别需要及时转诊至专科PC的情况,如低PPS评分。